Apogee Therapeutics Inc. (APGE)
Market Closed
4 Sep, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
135. 07
0
0%
$
8.4B Market Cap
- P/E Ratio
- Div Yield
5.14M Volume
- Eps
$ 135.07
Previous Close 
Want to track APGE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Apogee Therapeutics Inc. (APGE) Statistics
Valuation metrics
Market Cap 8.4B
Enterprise value 8.3B
Trailing P/E (ttm) -31.12
Forward P/E -
PEG ratio 6.57
Price/Sales (ttm) -
Price/Book (mrq) 8.53
Enterprise Value/Revenue -
Enterprise Value/EBITDA -28.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 568.6K
Average volume (90 days) 1.11M
Price summary
52-Week low 35.39
52-Week high 135.09
Beta -
50-Day moving average 134.89
200-Day moving average 94.65
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.88
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 26.44%
Book value per share (mrq) 15.83
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
